AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
New Fortress Energy
NFE
Cars.com
CARS
4
Halozyme Therapeutics
HALO
5
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -24.86%103.41M | -32.14%24.7M | -18.69%31.27M | -1.00%22.85M | -38.05%24.58M | 9.86%137.62M | 0.30%36.41M | 11.92%38.46M | 3.70%23.08M | 22.61%39.67M |
Net income from continuing operations | -767.64%-135.52M | -29.65%-21.15M | -7.83%11.42M | -816.04%-68.69M | -1,259.04%-57.11M | -133.38%-15.62M | -485.85%-16.31M | 160.54%12.39M | -121.65%-7.5M | -114.80%-4.2M |
Operating gains losses | ---144K | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | 20.87%40.63M | 27.01%11.08M | 13.62%10.09M | 12.65%8.96M | 30.34%10.49M | -2.85%33.61M | 4.55%8.73M | 2.04%8.88M | -10.18%7.95M | -7.41%8.05M |
Deferred tax | -8.75%-1.13M | 102.05%9K | -33.54%-852K | -22.76%-151K | -186.16%-137K | 49.19%-1.04M | -173.75%-438K | 48.42%-638K | 18.00%-123K | 131.80%159K |
Other non cash items | -24.81%6.27M | -37.44%1.77M | -50.65%1.4M | -52.10%1.05M | 327.35%2.05M | -33.11%8.33M | -65.57%2.83M | 52.73%2.83M | 1,287.34%2.19M | -78.38%479K |
Change In working capital | 148.41%701K | -17.32%2.48M | 48.95%6.97M | 43.20%-4.15M | -151.36%-4.61M | 46.92%-1.45M | 285.94%3M | -24.82%4.68M | 32.49%-7.3M | -152.84%-1.83M |
-Change in receivables | 199.54%4.53M | 241.39%1.57M | 136.38%390K | -63.66%1.44M | 161.74%1.13M | 149.27%1.51M | 340.31%459K | 52.36%-1.07M | 250.11%3.96M | -191.29%-1.84M |
-Change in other current liabilities | 71.48%-898K | 7.62%2.7M | 37.39%6.2M | 67.36%-3.07M | -774.77%-6.73M | 34.53%-3.15M | 148.88%2.51M | -49.56%4.51M | 2.26%-9.4M | -177.76%-769K |
-Change in other working capital | -1,650.26%-2.93M | -4,916.22%-1.78M | -69.00%385K | -35.32%-2.52M | 27.79%984K | -96.33%189K | -99.00%37K | 365.38%1.24M | -228.99%-1.86M | 63.14%770K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -24.86%103.41M | -32.14%24.7M | -18.69%31.27M | -1.00%22.85M | -38.05%24.58M | 9.86%137.62M | 0.30%36.41M | 11.92%38.46M | 3.70%23.08M | 22.61%39.67M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -18.50%313.08M | -50.13%77.42M | 188.08%89.4M | -47.89%66.84M | 14.08%79.43M | 330.01%384.16M | -57.74%155.25M | 171.95%31.03M | 895.72%128.25M | 131.82%69.62M |
Net business purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net investment purchase and sale | -32.04%1.47M | ---- | ---- | ---- | ---- | -94.03%2.16M | ---- | ---- | ---- | ---- |
Net other investing changes | -23.22%298.1M | -50.15%76.79M | 124.52%72.81M | -48.91%66.71M | 14.80%81.79M | 1,123.87%388.27M | -53.73%154.03M | 174.06%32.43M | 341.29%130.56M | 126.10%71.25M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -18.50%313.08M | -50.13%77.42M | 188.08%89.4M | -47.89%66.84M | 14.08%79.43M | 330.01%384.16M | -57.74%155.25M | 171.95%31.03M | 895.72%128.25M | 131.82%69.62M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 41.29%-327.95M | 44.67%-90.41M | 176.43%29.66M | 55.46%-107.78M | -39.34%-159.41M | -245.99%-558.6M | 58.78%-163.41M | -336.79%-38.8M | -427.29%-241.99M | -167.32%-114.41M |
Net issuance payments of debt | 54.07%-204.7M | 50.62%-67.67M | 691.81%70.19M | 63.17%-77.84M | -51.46%-129.38M | -6,390.04%-445.67M | 62.97%-137.02M | -169.02%-11.86M | -242.16%-211.37M | -143.29%-85.42M |
Net common stock issuance | -287.45%-11.18M | -150.00%-40K | ---6.98M | -19,200.00%-191K | -38.08%-3.96M | 93.58%-2.89M | -1,500.00%-16K | --0 | 100.00%1K | -187.58%-2.87M |
Cash dividends paid | 4.71%-99.06M | 20.02%-20.8M | -0.90%-26.23M | -0.18%-26.04M | -0.12%-26M | -4.59%-103.95M | -0.80%-26M | -1.71%-26M | -7.84%-25.99M | -8.48%-25.96M |
Net other financing activities | -113.54%-13.01M | -418.53%-1.9M | -679.66%-7.32M | 19.88%-3.71M | 51.30%-75K | 40.47%-6.09M | 38.01%-367K | -86.31%-939K | 30.76%-4.63M | 93.71%-154K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 41.29%-327.95M | 44.67%-90.41M | 176.43%29.66M | 55.46%-107.78M | -39.34%-159.41M | -245.99%-558.6M | 58.78%-163.41M | -336.79%-38.8M | -427.29%-241.99M | -167.32%-114.41M |
Net cash flow | ||||||||||
Beginning cash position | -9.21%362.09M | 31.63%439.15M | -4.63%288.73M | -22.18%306.24M | -9.21%362.09M | 15.08%398.83M | -14.74%333.63M | -26.05%302.76M | 19.05%393.54M | 15.08%398.83M |
Current changes in cash | 340.49%88.54M | -58.53%11.72M | 389.72%150.33M | 80.04%-18.1M | -983.71%-55.41M | -169.25%-36.82M | 290.54%28.25M | 273.92%30.7M | -213.21%-90.65M | 69.01%-5.11M |
Effect of exchange rate changes | -10.39%69K | -179.33%-165K | -50.29%87K | 537.31%586K | -155.23%-439K | 108.57%77K | -22.96%208K | 139.59%175K | 89.03%-134K | -134.68%-172K |
End cash Position | 24.47%450.7M | 24.47%450.7M | 31.63%439.15M | -4.63%288.73M | -22.18%306.24M | -9.21%362.09M | -9.21%362.09M | -14.74%333.63M | -26.05%302.76M | 19.05%393.54M |
Free cash flow | -24.86%103.41M | -32.14%24.7M | -18.69%31.27M | -1.00%22.85M | -38.05%24.58M | 9.86%137.62M | 0.30%36.41M | 11.92%38.46M | 3.70%23.08M | 22.61%39.67M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |